The advantages of the process are in the production of biologically active proteins, exosomes, and signaling molecules, developing a "systems therapeutic" yielding a combination of many molecules, that act at multiple targets, resulting in a synergistic therapeutic with emergent therapeutic value.
We found that cells expressing the w/o cyto CX3CL1 displayed only a 4-nN dissociation force toward cells expressing the CX3CR1 receptor, whereas the native molecule developed a 5-nN force (Fig. 1E) for a similar number of positive adhesive events (Fig. 1F).
Consequently, we investigated the hypothesis that mice that lack selectin molecules develop accelerated CIA as a result of altered cytokine expression.
As evidence, he points to the oxidised mineral form of the element molybdenum, thought to be a catalyst that helped organic molecules develop into the first living structures.
The vast majority of these methods (supervised learning) needs a training set of objects (molecules) to develop a decision rule that can be used to classify new entities (the test set) into one of the two mentioned classes [1].
Dr. van Kooyk suggested that scientists might find a way to use the molecule to develop a vaccine.
The Smxyl promoter was used for construction of a vector molecule to develop a one-step FLP/FRT recombination system in A. chrysogenum.
One class of molecules developed was hydroxamate compounds with a linear diacetylene scaffold, such as LPC-009 and LPC-011 (Liang et al., 2011).
This group had a breakthrough paper in 2012, determining the Lis1-binding domain on the dynein motor domain, and using elegant single molecule studies to develop a clutch model for Lis1-mediated regulation of dynein motility.
Can science tell us what it means to be human, or how molecules developed the ability to think, as they seem to do in the brain?
